World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01899365
Date of registration: 04/07/2013
Prospective Registration: Yes
Primary sponsor: Centre Hospitalier Princesse Grace
Public title: An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department IMPROVED
Scientific title: An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department; A Multicenter Prospective Randomized Open Trial The IMPROVED Project
Date of first enrolment: November 2015
Target sample size: 1475
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01899365
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France Monaco
Contacts
Name:     Jocelyn RAUDE, PHD
Address: 
Telephone:
Email:
Affiliation:  Ecole des Hautes Etudes en Santé Publique
Name:     José LABARERE, MD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Grenoble
Name:     Yann-Erick CLAESSENS, MD-PHD
Address: 
Telephone:
Email:
Affiliation:  Centre Hospitalier Princesse Grace
Name:     Xavier DUVAL, MD-PHD
Address: 
Telephone:
Email:
Affiliation:  Groupe Hospitalier Bichat Claude-Bernard
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients 65-year old and above,

- benefit from French or Monaco social security a social security.

Exclusion Criteria:

- refuse to participate,

- no possibility to receive SMS,

- impaired cognitive functions and mental status precluding understanding of the study,

- anticipated barriers precluding adequate follow-up (ex. homeless),

- previous APV,

- contraindication to APV,

- do not understand/read French.



Age minimum: 65 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Pneumococcal Infections
Intervention(s)
Primary Outcome(s)
Impact of a multifaceted procedure at ED visit on anti-pneumococcal vaccination. (APV) at 6-month. Evaluation criteria : ? percentage (%) of APV vaccination at 6-month [Time Frame: 6 month]
Secondary Outcome(s)
On death at 6- and 12-month (absolute number of events) [Time Frame: 6 month]
On death related to infection at 6- and 12-month (absolute number of events) [Time Frame: 6 month]
On episodes of respiratory tract infections requiring antibiotics or admission at 6-month ? (absolute number of events) [Time Frame: 6 month]
On Flu vaccination at 6-month ? percentage (%) [Time Frame: 6 month]
Psychosocial evaluation of patients and acceptance / refusal of vaccination [Time Frame: 6 month]
Secondary ID(s)
12-09
2013-A00943-42
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Pfizer
Centre Scientifique de Monaco
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history